Herbalife (NYSE: HLF ) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Herbalife's revenues will expand 12.4% and EPS will grow 7.3%.
The average estimate for revenue is $1.16 billion. On the bottom line, the average EPS estimate is $1.18.
Last quarter, Herbalife booked revenue of $1.12 billion. GAAP reported sales were 17% higher than the prior-year quarter's $964.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.27. GAAP EPS of $1.10 for Q1 were 25% higher than the prior-year quarter's $0.88 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 47.5%, 80 basis points better than the prior-year quarter. Operating margin was 15.0%, 100 basis points worse than the prior-year quarter. Net margin was 10.6%, 60 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $4.63 billion. The average EPS estimate is $4.80.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 459 members out of 661 rating the stock outperform, and 202 members rating it underperform. Among 191 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 120 give Herbalife a green thumbs-up, and 71 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Herbalife is outperform, with an average price target of $61.43.
Looking for alternatives to Herbalife? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Herbalife to My Watchlist.